Text: S.2553 — 115th Congress (2017-2018)All Information (Except Text)

Text available as:

Shown Here:
Referred in House (09/05/2018)

 
[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 2553 Referred in House (RFH)]

<DOC>






115th CONGRESS
  2d Session
                                S. 2553


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 5, 2018

 Referred to the Committee on Energy and Commerce, and in addition to 
   the Committee on Ways and Means, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 AN ACT


 
  To amend title XVIII of the Social Security Act to prohibit health 
 plans and pharmacy benefit managers from restricting pharmacies from 
   informing individuals regarding the prices for certain drugs and 
                              biologicals.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Know the Lowest Price Act of 2018''.

SEC. 2. PROHIBITION ON LIMITING CERTAIN INFORMATION ON DRUG PRICES.

    (a) In General.--Section 1860D-4 of the Social Security Act (42 
U.S.C. 1395w-104) is amended by adding at the end the following new 
subsection:
    ``(m) Prohibition on Limiting Certain Information on Drug Prices.--
A PDP sponsor and a Medicare Advantage organization shall ensure that 
each prescription drug plan or MA-PD plan offered by the sponsor or 
organization does not restrict a pharmacy that dispenses a prescription 
drug or biological from informing, nor penalize such pharmacy for 
informing, an enrollee in such plan of any differential between the 
negotiated price of, or copayment or coinsurance for, the drug or 
biological to the enrollee under the plan and a lower price the 
individual would pay for the drug or biological if the enrollee 
obtained the drug without using any health insurance coverage.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to plan years beginning on or after January 1, 2020.

            Passed the Senate September 4, 2018.

            Attest:

                                                JULIE E. ADAMS,

                                                             Secretary.